NHS Dudley Health Economy Medicines Formulary
Home > 8 Malignant disease and immunosuppression > 8.2 Drugs affecting the immune response > 8.2.4 Other immunomodulating drugs > Dimethyl fumarate for treating relapsing‑remitting multiple sclerosis - NICE TAG TA320

Dimethyl fumarate for treating relapsing‑remitting multiple sclerosis - NICE TAG TA320

1.1 Dimethyl fumarate is recommended as an option for treating adults with active relapsing‑remitting multiple sclerosis (normally defined as 2 clinically significant relapses in the previous 2 years), only if:


•they do not have highly active or rapidly evolving severe relapsing‑remitting multiple sclerosis and


•the manufacturer provides dimethyl fumarate with the discount agreed in the patient access scheme.


1.2 People currently receiving treatment initiated within the NHS with dimethyl fumarate that is not recommended for them by NICE in this guidance should be able to continue treatment until they and their NHS clinician consider it appropriate to stop.

http://www.nice.org.uk/guidance/TA320

Site by Devopa
© Copyright 2020 NHS. All rights reserved.